ARM LYMPHEDEMA RATES IN BREAST CANCER PATIENTS WITH NEOADJUVANT CHEMOTHERAPY AFTER AXILLARY LYMPH NODE DISSECTION VERSUS TARGETED AXILLARY DISSECTION: A PROSPECTIVE COHORT STUDY